NYSEMaterialsChemicals - SpecialtySnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Annual ending 2026-12-31 | ||
| Revenue | — | 2.47B |
| EPS | — | 0 |
Management figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Enhance cash from operations to at least $124 million | Cash from operations improved to $124 million in Q1 2026. | Intact | cash from operations falls below $120 million next year | Cash from operations: $187.144M FY2026-Q2; GAAP. Published target: >= $124 million. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026187,144,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain dividend payout at $3.00 per share | NewMarket keeps paying and slightly raising dividends, now $3.00 per share. | Intact | dividend per share falls below $3.00 next year | Dividend per share: $3.00 per share FY2026-Q2; GAAP. Published target: >= $3.00 per share. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Jul 30, 20263 USD/share · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ad090f6f-ebc1-492f-b24e-fb71e98bd4f6. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain operating income near $143 million | A primary condition in NewMarket Corporation's published investment case. The stated target is >= $140 million. | Intact | operating income falls below $140 million next year | Operating income: $163.665M FY2026-Q2; GAAP. Published target: >= $140 million. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026163,665,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ad090f6f-ebc1-492f-b24e-fb71e98bd4f6. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Oct 28, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
NEU is a materials business with a growth and execution thesis, supported by specialty materials expansion and steady dividend payouts. The multi-year view is intact, but recent company momentum has weakened and the sector backdrop is a headwind.
Valuation is stretched, with NEU at a premium to peers and expectations ahead of the model’s baseline. The expectations gap is meaningful, while low fragility suggests the priced-in setup is not especially vulnerable to a single regime factor.
Near term, management’s record is mixed: recent financial performance is strong, and specialty materials sales and operating profit have grown, but company momentum fell sharply. Capacity is expected online by the end of 2026, while cost control and dividend priorities remain on track; a guidance cut or another earnings miss is a risk.
Over the next few quarters, the thesis depends on management sustaining execution and bringing new specialty materials capacity online without weakening guidance. Sector signals also matter: continued strength from LIN, SHW, and ECL could support Materials momentum, while weaker results or guidance from them could remove that tailwind.
For the 1-3 year view, NEU has solid recent results and clear execution priorities, but its stretched valuation and fading momentum leave limited room for weaker guidance or a less supportive sector backdrop. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.